Impact of COVID-19 pandemic on prevalence of Clostridioides difficile infection in a UK tertiary centre.


Journal

Anaerobe
ISSN: 1095-8274
Titre abrégé: Anaerobe
Pays: England
ID NLM: 9505216

Informations de publication

Date de publication:
Feb 2022
Historique:
received: 16 09 2021
revised: 13 11 2021
accepted: 15 11 2021
pubmed: 22 11 2021
medline: 17 3 2022
entrez: 21 11 2021
Statut: ppublish

Résumé

Serious concerns have been raised about a possible increase in cases of Clostridioides difficile infection (CDI) during the COVID-19 pandemic. We conducted a retrospective observational single centre study which revealed that total combined community and hospital-based quarterly rates of CDI decreased during the pandemic compared to the pre-pandemic period.

Identifiants

pubmed: 34801705
pii: S1075-9964(21)00162-1
doi: 10.1016/j.anaerobe.2021.102479
pmc: PMC8607812
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

102479

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: T.M. is a consultant advisor for Takeda. All other authors declare that they have no conflicts of interest.

Références

Infect Drug Resist. 2021 Apr 28;14:1645-1648
pubmed: 33953575
J Clin Med. 2020 Nov 27;9(12):
pubmed: 33260943
JGH Open. 2021 Mar 30;5(5):622-625
pubmed: 34013064
Emerg Infect Dis. 2009 May;15(5):802-5
pubmed: 19402975
Infect Control Hosp Epidemiol. 2021 Sep;42(9):1165-1166
pubmed: 32962772
Scand J Public Health. 2013 Jul;41(5):541-5
pubmed: 23503193
Anaerobe. 2014 Jun;27:31-3
pubmed: 24657158
PLoS One. 2015 Mar 16;10(3):e0120730
pubmed: 25775463
Am J Infect Control. 2021 May;49(5):640-642
pubmed: 33031863
Adv Exp Med Biol. 2018;1050:227-243
pubmed: 29383672
Infect Control Hosp Epidemiol. 2021 Apr;42(4):406-410
pubmed: 32895065
Pol Arch Intern Med. 2021 Feb 26;131(2):118-120
pubmed: 33641318
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32441243
Pol Arch Intern Med. 2021 Feb 26;131(2):121-127
pubmed: 33314875
Sci Rep. 2017 Feb 01;7:41196
pubmed: 28145453

Auteurs

Sanjana Voona (S)

School of Medicine, University of Nottingham, England, UK.

Heather Abdic (H)

Department of Gastroenterology, Nottingham University Hospitals NHS Trust, England, UK.

Ros Montgomery (R)

Infection Prevention & Control, Nottingham University Hospitals NHS Trust, England, UK.

Annette Clarkson (A)

Pharmacy Department, Nottingham University Hospitals NHS Trust, UK.

Hannah Twitchell (H)

Pharmacy Department, Nottingham University Hospitals NHS Trust, UK.

Tim Hills (T)

Pharmacy Department, Nottingham University Hospitals NHS Trust, UK.

Steve Briggs (S)

Quality and Nursing, Information & Insight Services, Finance & Procurement, Nottingham University Hospitals NHS Trust, UK.

Colin Crooks (C)

NIHR Nottingham Biomedical Research Centre, University of Nottingham, England, UK; Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, England, UK.

Tanya M Monaghan (TM)

NIHR Nottingham Biomedical Research Centre, University of Nottingham, England, UK; Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, England, UK. Electronic address: tanya.monaghan@nottingham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH